Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00392990
Status:
COMPLETED
Last Update Posted:
2019-10-15
First Post:
2006-10-25
Brief Title:
Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitts Lymphoma or Burkitt-Like Lymphoma
Sponsor:
Northwestern University
Organization:
Northwestern University
Organization Data
Organization:
Northwestern University
Class:
OTHER
Study ID:
NU 06H2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Northwestern University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |